Evaluation of concurrent radiation, temozolomide and ABT-888 treatment followed by maintenance therapy with temozolomide and ABT-888 in a genetically engineered glioblastoma mouse model

Authors

Benjamin Lemasson, University Joseph Fourier
Hanxiao Wang, University of Michigan-Ann Arbor
Stefanie Galban, University of Michigan-Ann Arbor
Yinghua Li, Washington University School of Medicine in St. Louis
Yuan Zhu, Washington University School of Medicine in St. Louis
Kevin A. Heist, University of Michigan-Ann Arbor
Christina Tsein, University of Michigan-Ann Arbor
Thomas L. Chenevert, University of Michigan-Ann Arbor
Alnawaz Rehemtulla, University of Michigan-Ann Arbor
Craig J. Galban, University of Michigan-Ann Arbor
Eric C. Holland, University of Washington - Seattle Campus
Brian D. Ross, University of Michigan-Ann Arbor

Journal

Neoplasia

Publication Date

2016

Volume

18

Issue

2

Inclusive Pages

82-89

Document Type

Open Access Publication

DOI

10.1016/j.neo.2015.11.014

Rights and Permissions

Benjamin Lemasson, et al. (2016) Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model. Neoplasia, 18(2): 82-89. DOI: 10.1016/j.neo.2015.11.014

Recommended Citation

Lemasson, Benjamin; Wang, Hanxiao; Galban, Stefanie; Li, Yinghua; Zhu, Yuan; Heist, Kevin A.; Tsein, Christina; Chenevert, Thomas L.; Rehemtulla, Alnawaz; Galban, Craig J.; Holland, Eric C.; and Ross, Brian D., "Evaluation of concurrent radiation, temozolomide and ABT-888 treatment followed by maintenance therapy with temozolomide and ABT-888 in a genetically engineered glioblastoma mouse model." Neoplasia. 18, 2. 82-89. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/4797